Tata Memorial Hospital (TMH), one of India’s leading cancer treatment and research institutions, has strengthened its diagnostic infrastructure with the installation of three state of the art Automated Pre-Analytical Tube Labelling (APTL) systems aimed at improving diagnostic accuracy, laboratory efficiency, and patient safety.

The advanced systems were inaugurated under a Corporate Social Responsibility (CSR) initiative supported by, with Maharashtra Chief Minister Devendra Fadnavis stating that the technology will significantly reduce human errors in sample handling and accelerate clinical decision making.

According to officials, the newly deployed APTL systems automate sample labelling and barcoding processes, minimizing risks related to misidentification, manual handling errors, and reporting delays  factors considered critical in oncology diagnostics where treatment timelines directly impact patient outcomes.

Tata Memorial Hospital handles one of the country’s largest cancer patient volumes and diagnostic workloads. Reports indicate the hospital processes nearly 3,000 diagnostic samples daily through its integrated laboratory network and pneumatic sample transport infrastructure operating across 54 collection stations.

Hospital data further shows that TMH performs more than 130,000 radiodiagnostic procedures annually, including CT scans, MRI, mammography, ultrasound, and interventional imaging services. The institution has also implemented NABL-accredited laboratory quality systems and digital pathology workflows to improve precision diagnostics and standardization across cancer care services.

Speaking on the development, Chief Minister Fadnavis noted that modern diagnostic automation is essential for improving transparency, speed, and reliability in healthcare delivery, particularly in critical disease management such as cancer treatment. He added that adoption of globally aligned laboratory technologies would strengthen Maharashtra’s healthcare ecosystem and improve patient trust.

The installation aligns with Tata Memorial Hospital’s broader push toward technology enabled precision oncology. The institution has increasingly invested in digital pathology, molecular diagnostics, AI assisted cancer detection systems, and advanced radiotherapy safety programs to enhance treatment outcomes and reduce diagnostic variability.

Industry estimates suggest that laboratory automation can reduce pre analytical diagnostic errors   which account for nearly 60–70% of total laboratory mistakes globally   while significantly improving turnaround time and patient safety standards in high volume hospitals.

Healthcare experts believe the deployment of automated diagnostic infrastructure at Tata Memorial Hospital could serve as a benchmark for public healthcare institutions across India seeking to modernize pathology and oncology workflows through digital transformation and automation driven quality systems.